Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Medulloblastoma × Tablets × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Sarcoma 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms 1 Meningioma 1 Medulloblastoma 1 Inflammation 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 32 Temozolomide 30 Filgrastim 24 Carboplatin 23 Etoposide 22 Vincristine 18 Radiotherapy 18 Cisplatin 18 Magnetic Resonance Spectroscopy 15 Thiotepa 13 Irinotecan 12 Granulocyte Colony-Stimulating Factor 11 Peripheral Blood Stem Cell Transplantation 10 Melphalan 9 Lomustine 9 Topotecan 8 Specimen Handling 8 Methotrexate 8 etoposide phosphate 7 Radiation 7 X-Rays 6 Phantoms, Imaging 6 Biopsy 6 sonidegib 5 sargramostim 5 Platinum 5 Nuclear Medicine Department, Hospital 5 Busulfan 5 Bevacizumab 5 1,2-diaminocyclohexaneplatinum II citrate 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05230758 2026-01-22

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡